Rapid and quantitative detection of SARS-CoV-2 IgG antibody in serum using optofluidic point-of-care testing fluorescence biosensor

The COVID-19 pandemic brings unprecedented disaster for public well being and economics on this planet. Detecting particular antibodies to SARS-CoV-2 is a strong complement for the prognosis of COVID-19 and is necessary for epidemiological research and vaccine validations.
Herein, a fast and quantitative detection technique of anti-SARS-CoV-2 IgG antibody was constructed based mostly on the optofluidic point-of-care testing fluorescence biosensor. With out difficult steps wanted, the moveable system is appropriate for on-site delicate willpower of anti-SARS-CoV-2 IgG antibody in serum.
Underneath the optimum circumstances, the entire detection process is about 25 min with a detection restrict of 12.5 ng/mL that may effectively meet the diagnostic necessities. The tactic was not clearly affected by IgM and serum matrix and demonstrated to have good stability and reliability in actual pattern evaluation.
In comparison with ELISA take a look at outcomes, the proposed technique reveals a number of benefits together with wider measurement vary and simpler operation. The tactic gives a common platform for fast and quantitative evaluation of different associated biomarkers, which is of significance for the prevention and management of COVID-19 pandemic.

Change to infliximab subcutaneous throughout SARS-CoV-2 pandemic: preliminary outcomes

A brand new subcutaneous formulation of the infliximab biosimilar CT-P13 has lately been developed for the remedy of inflammatory bowel illness (IBD), offering response charges much like intravenous remedy. In an effort to restrict affected person attendance at intravenous infusion facilities and to keep up organic remedy in the course of the COVID-19 pandemic, using this new formulation was requested.
The target of this observational, retrospective, and descriptive examine was to evaluate CT-P13 efficacy and security after switching from intravenous to subcutaneous formulation in sufferers with IBD receiving upkeep remedy. This text reveals preliminary outcomes after six months of follow-up.

Neutralizing Monoclonal Antibodies That Goal the Spike Receptor Binding Area Confer Fc Receptor-Unbiased Safety towards SARS-CoV-2 An infection in Syrian Hamsters

The extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein is the principle goal for neutralizing antibodies. These antibodies might be elicited by immunization or passively transferred as therapeutics within the type of convalescent-phase sera or monoclonal antibodies (MAbs). Potently neutralizing antibodies are anticipated to confer safety; nonetheless, it’s unclear whether or not weakly neutralizing antibodies contribute to safety.
Additionally, their mechanism of motion in vivo is incompletely understood. Right here, we exhibit that 2B04, an antibody with an ultrapotent neutralizing exercise (50% inhibitory focus [IC50] of 0.04 μg/ml), protects hamsters towards SARS-CoV-2 in a prophylactic and therapeutic an infection mannequin.
Safety is related to diminished weight reduction and viral hundreds in nasal turbinates and lungs after problem. MAb 2B04 additionally blocked aerosol transmission of the virus to naive contacts. We subsequent examined three further MAbs (2C02, 2C03, and 2E06), recognizing distinct epitopes inside the receptor binding area of spike protein that possess both minimal (2C02 and 2E06, IC50 > 20 μg/ml) or weak (2C03, IC50 of 5 μg/ml) virus neutralization capability in vitro. Solely 2C03 protected Syrian hamsters from weight reduction and diminished lung viral load after SARS-CoV-2 an infection.
Lastly, we demonstrated that Fc-Fc receptor interactions weren’t required for cover when 2B04 and 2C03 had been administered prophylactically. These findings inform the mechanism of safety and help the rational growth of antibody-mediated safety towards SARS-CoV-2 infections. IMPORTANCE The continuing coronavirus illness 2019 (COVID-19) pandemic, brought on by SARS-CoV-2, has resulted within the lack of thousands and thousands of lives.
Secure and efficient vaccines are thought-about the final word treatment for the worldwide social and financial disruption brought on by the pandemic. Nevertheless, an intensive understanding of the immune correlates of safety towards this virus is missing. Right here, we characterised 4 completely different monoclonal antibodies and evaluated their skill to forestall or deal with SARS-CoV-2 an infection in Syrian hamsters. These antibodies different of their skill to neutralize the virus in vitro.
Prophylactic administration of potent and weakly neutralizing antibodies protected towards SARS-CoV-2 an infection, and this impact was Fc receptor unbiased. The potent neutralizing antibody additionally had therapeutic efficacy and eradicated onward aerosol transmission.
In distinction, minimally neutralizing antibodies supplied no safety towards an infection with SARS-CoV-2 in Syrian hamsters. Mixed, these research spotlight the importance of weakly neutralizing antibodies within the safety towards SARS-CoV-2 an infection and related illness.

Manufacturing of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interplay chromatography hyphenated to multi-angle mild scattering detection

The nucleocapsid protein (NP) of extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is vital for a number of steps of the viral life cycle, and is abundantly expressed throughout an infection, making it a really perfect diagnostic goal protein.
This protein has a robust tendency for dimerization and interplay with nucleic acids. For the primary time, excessive titers of NP had been expressed in E. coli with a CASPON tag, utilizing a growth-decoupled protein expression system.
Purification was completed by nuclease remedy of the cell homogenate and a sequence of downstream processing (DSP) steps. An analytical technique consisting of native hydrophobic interplay chromatography hyphenated to multi-angle mild scattering detection (HIC-MALS) was established for in-process management, specifically, to observe product fragmentation and multimerization all through the purification course of.
730 mg purified NP per liter of fermentation may very well be produced by the optimized course of, equivalent to a yield of 77% after cell lysis. The HIC-MALS technique was used to exhibit that the NP product might be produced with a purity of 95%. The molecular mass of the principle NP fraction is according to dimerized protein as was verified by a complementary native size-exclusion separation (SEC)-MALS evaluation.
Peptide mapping mass spectrometry and host cell particular enzyme-linked immunosorbent assay confirmed the excessive product purity, and the presence of a minor endogenous chaperone defined the residual impurities.

SARS Spike Antibody

24318-100ul 100ul
EUR 390

SARS Spike Antibody

20-abx137184
  • EUR 1052.00
  • EUR 1539.00
  • EUR 1720.00
  • 100 ug
  • 200 ug
  • 300 µg
  • Shipped within 5-10 working days.

SARS Spike Antibody

20-abx137200
  • EUR 1177.00
  • EUR 1887.00
  • EUR 2221.00
  • 100 ug
  • 200 ug
  • 300 µg
  • Shipped within 5-10 working days.

SARS-CoV Spike Protein

abx060655-1mg 1 mg
EUR 1692
  • Shipped within 5-10 working days.

SARS-CoV spike protein Antibody

abx023139-100ug 100 ug
EUR 857
  • Shipped within 5-10 working days.

SARS-CoV spike protein Antibody

abx023143-100ug 100 ug
EUR 857
  • Shipped within 5-10 working days.

Recombinant 2019-nCoV coronavirus Spike protein S1 subunit

Spike-191V 100ug
EUR 792
  • Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 mg/ml. Centrifuge the vial at +4 degrees Celsius before opening to recover the entire contents.
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to His tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV.

Recombinant 2019-nCoV coronavirus Spike protein S1 subunit

Spike-192V 100ug
EUR 792
  • Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 mg/ml. Centrifuge the vial at +4 degrees Celsius before opening to recover the entire contents.
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to to Human IgG1 Fc tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV.

Recombinant 2019-nCoV coronavirus Spike protein S1 subunit

Spike-193V 100ug
EUR 1610
  • Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 mg/ml. Centrifuge the vial at +4 degrees Celsius before opening to recover the entire contents.
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to to Mouse IgG1 Fc tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV.

Recombinant 2019-nCoV coronavirus Spike protein, S1+S2 ECD

Spike-194V 100ug
EUR 1610
  • Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 mg/ml. Centrifuge the vial at +4 degrees Celsius before opening to recover the entire contents.
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein (S1+S2 ECD) was fused to His-tag at C-terminus and expressed in Baculovirus-Insect cell. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell.S1 mainly contains a receptor binding domain (RBD) and recognize the cell surface receptor. S2 essential for membrane fusion. S protein are important for neutralizing-antibody and T-cell responses, as well as protective immunity.

Recombinant SARS Coronavirus Spike, GST-Tagged

DAG534 1mg
EUR 1556

Sars-Cov, Spike (Middle) Recom Protein

abx060656-1mg 1 mg
EUR 1692
  • Shipped within 5-10 working days.

SARS Associated Spike Mosaic S Protein

20-abx260156
  • EUR 885.00
  • EUR 342.00
  • EUR 1372.00
  • 0.5 mg
  • 100 ug
  • 1 mg
  • Shipped within 5-10 working days.

Mouse Monoclonal Anti-SARS Spike IgG

AB-17910 50 ug
EUR 469

Recombinant SARS Spike gp C Protein

VAng-Lsx0072-inquire inquire Ask for price
Description: SARS Spike glycoprotein C, recombinant protein from E. coli.

Recombinant 2019-nCoV coronavirus Spike protein S1 subunit receptor binding domain

Spike-19V 100ug
EUR 792
  • Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 mg/ml. Centrifuge the vial at +4 degrees Celsius before opening to recover the entire contents.
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit receptor binding domain (RBD) was fused to Mouse IgG1 Fc tag at C-terminus and expressed in human cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell: they are essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit contains a receptor-binding domain that engages with the host cell receptor angiotensin-converting enzyme 2 and the S2 subunit mediates fusion between the viral and host cell membranes. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV.

Recombinant 2019-nCoV coronavirus Spike protein, S1 subunit, expressed in Baculovirus-Insect cells

Spike-195V 100ug
EUR 1610
  • Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 mg/ml. Centrifuge the vial at +4 degrees Celsius before opening to recover the entire contents.
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein S1 subunit was fused to His-tag at C-terminus and expressed in Baculovirus-Insect cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell.S1 mainly contains a receptor binding domain (RBD) and recognize the cell surface receptor. S2 essential for membrane fusion. S protein are important for neutralizing-antibody and T-cell responses, as well as protective immunity.

Recombinant 2019-nCoV coronavirus Spike protein, S2 ECD, expressed in Baculovirus-Insect cells

Spike-197V 100ug
EUR 1610
  • Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.25 mg/ml. Centrifuge the vial at +4 degrees Celsius before opening to recover the entire contents.
Description: Recombinant COVID-19 (2019 novel coronavirus) Spike protein (S2 ECD) was fused to His-tag at C-terminus and expressed in Baculovirus-Insect cells. The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell.S1 mainly contains a receptor binding domain (RBD) and recognize the cell surface receptor. S2 essential for membrane fusion. S protein are important for neutralizing-antibody and T-cell responses, as well as protective immunity.

Recombinant SARS Associated Spike Mosaic S(N)

7-07093 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S(N)

7-07094 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S(N)

7-07095 1000µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)

7-07096 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)

7-07097 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)

7-07098 1000µg Ask for price

Recombinant SARS Associated Spike Mosaic S©

7-07099 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S©

7-07100 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S©

7-07101 1000µg Ask for price

anti-SARS spike glycoprotein antibody (clone 3A2)

65-101 50ug
EUR 296
Description: The anti-SARS spike glycoprotein antibody (clone 3A2) is available in Europe and for worldwide shipping via Gentaur.

Sars-Cov, Spike (N-Term) Recom Protein

abx060657-1mg 1 mg
EUR 1873
  • Shipped within 5-10 working days.

SARS Associated Spike Mosaic S(M) Protein

20-abx260155
  • EUR 885.00
  • EUR 342.00
  • EUR 1372.00
  • 0.5 mg
  • 100 ug
  • 1 mg
  • Shipped within 5-10 working days.

SARS Associated Spike Mosaic S(N) Protein

20-abx260157
  • EUR 885.00
  • EUR 342.00
  • EUR 1372.00
  • 0.5 mg
  • 100 ug
  • 1 mg
  • Shipped within 5-10 working days.

Mouse Monoclonal Anti-SARS Spike Protein IgG

AB-15710 20 ug
EUR 408

Recombinant (E.Coli) SARS Associated Spike Mosaic S

RP-1422 100 ug
EUR 286

Recombinant (E.Coli) SARS Associated Spike Mosaic S

RP-1423 100 ug
EUR 286

Recombinant (E.Coli) SARS Associated Spike Mosaic S

RP-1424 100 ug
EUR 286

Anti-SARS-CoV-2 Spike S1 Antibody

A3000-50 50 µg
EUR 419

Recombinant Coronavirus Spike Protein (SARS-CoV S2)

P1519-10 10µg
EUR 156

Recombinant Coronavirus Spike Protein (SARS-CoV S2)

P1519-50 50µg
EUR 551

SARS Blocking Peptide

33R-8713 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SARS antibody, catalog no. 70R-1445

SARS Blocking Peptide

33R-7048 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SARS antibody, catalog no. 70R-1444

Recombinant SARS Coronavirus Spike (C-term), GST-Tagged

DAG539 1mg
EUR 1556

Recombinant SARS-CoV Spike protein [GST] (37 kDa)

VAng-Wyb8620-inquire inquire Ask for price
Description: SARS-CoV C-terminal of the Spike protein (37 kDa), recombinant protein from E. coli, 1 mg/mL.

Recombinant SARS-CoV Spike protein [GST] (38 kDa)

VAng-Wyb8621-inquire inquire Ask for price
Description: SARS-CoV middle region of the Spike protein (38 kDa), recombinant protein from E. coli, 1 mg/mL.

Recombinant SARS Spike Protein (aa 1-1190) [His]

VAng-Lsx0063-inquire inquire Ask for price
Description: SARS Spike protein (aa 1-1190) [His], recombinant protein from HEK 293 cells.

Recombinant SARS Spike Mosaic Protein S (N-Terminal)

VAng-Lsx0073-inquire inquire Ask for price
Description: SARS spike mosaic protein S (N-terminal), recombinant protein from E. coli.

Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD)

P1533-10 10 µg Ask for price

Recombinant Coronavirus Spike Protein (SARS-CoV-2; ECD)

P1533-50 50 µg Ask for price

Recombinant Coronavirus SARS Associated Spike (N-terminal), GST-tagged

DAG547 1mg
EUR 1535

SARS-CoV-2 Spike RBD protein antibody pair 1

CSB-EAP33245 1 pair
EUR 750
  • The recommended concentrations for analysis performance are 1ug/ml for the capture antibody and 0.42ug/ml for the detection antibody, respectively. The optimal dilutions should be determined experimentally by the researcher.
Description: This is a set of capture antibody and HRP-conjugated antbody for quantitative detection of SARS-CoV-2 Spike RBD protein for through solid phase sandwich ELISA.

Recombinant (HEK) SARS Coronavirus Spike S1 protein (His-tag)

SARSS15-R-10 10 ug
EUR 347

Anti-SARS-CoV-2 Spike S1 Antibody (Clone# 4C6)

A3001-50 50 µg
EUR 419

Recombinant Coronavirus Spike Protein (SARS-CoV S1; His tag)

P1516-10 10µg
EUR 257

Recombinant Coronavirus Spike Protein (SARS-CoV S, His tag)

P1520-10 10µg
EUR 257

Recombinant SARS-CoV-2 Spike Protein S1 (His-tag)

P1540-10 10 µg
EUR 176

Recombinant SARS-CoV-2 Spike Protein S1 (His-tag)

P1540-50 50 µg
EUR 682

Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag)

P1541-10 10 µg
EUR 176

Recombinant SARS-CoV-2 Spike Protein S1 (Fc tag)

P1541-50 50 µg
EUR 682

Recombinant Coronavirus Spike Protein (SARS-CoV-2; His tag)

P1528-10 10 µg Ask for price

Recombinant Coronavirus Spike Protein (SARS-CoV-2; His tag)

P1528-50 50 µg Ask for price

Recombinant SARS Coronavirus Spike S1 Protein (aa 1-667) [His]

VAng-Wyb7337-100g 100 µg
EUR 1747
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike S1 protein, recombinant protein.

Recombinant SARS Coronavirus Spike S1 Protein (aa 1-667) [His]

VAng-Wyb7337-20g 20 µg
EUR 628
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike S1 protein, recombinant protein.

Recombinant SARS Coronavirus Spike S1 Protein (aa 1-667) [His]

VAng-Wyb7337-50g 50 µg
EUR 1105
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike S1 protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His]

VAng-Wyb7338-100g 100 µg
EUR 1747
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His]

VAng-Wyb7338-20g 20 µg
EUR 628
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [His]

VAng-Wyb7338-50g 50 µg
EUR 1105
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc]

VAng-Wyb7339-100g 100 µg
EUR 1747
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc]

VAng-Wyb7339-20g 20 µg
EUR 628
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Recombinant SARS Coronavirus Spike (RBD) Protein (aa 306-527) [Fc]

VAng-Wyb7339-50g 50 µg
EUR 1105
Description: severe acute respiratory syndrome coronavirus (isolate:WH20) Spike protein, recombinant protein.

Human CellExp™ SARS-CoV-2 Spike Protein (RBD), Recombinant

P1530-10 10 µg
EUR 156

Human CellExp™ SARS-CoV-2 Spike Protein (RBD), Recombinant

P1530-50 50 µg
EUR 591

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2), Recombinant

P1547-10 10 μg
EUR 196

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2), Recombinant

P1547-50 50 μg
EUR 652

Human CellExp™ SARS-CoV-2 Spike Protein (S1), Recombinant

P1555-10 10μg
EUR 196

Human CellExp™ SARS-CoV-2 Spike Protein (S1), Recombinant

P1555-50 50μg
EUR 591

Human CellExp™ SARS-CoV-2 Spike Protein (S1), Recombinant

P1531-10 10 µg Ask for price

Human CellExp™ SARS-CoV-2 Spike Protein (S1), Recombinant

P1531-50 50 µg Ask for price

Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573)

VAng-Lsx0056-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 408-470, 540-573 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant Coronavirus Spike Protein (SARS-CoV S2; 408-470, 540-573)

P1518-10 10µg
EUR 156

Recombinant Coronavirus Spike Protein (SARS-CoV S2; 408-470, 540-573)

P1518-50 50µg
EUR 551

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; S1), Recombinant

P1524-10 10 µg
EUR 277

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; S2), Recombinant

P1525-10 10 µg
EUR 277

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; RBD), Recombinant

P1529-10 10 µg Ask for price

Human CellExp™ Coronavirus Spike Protein (SARS-CoV-2; RBD), Recombinant

P1529-50 50 µg Ask for price

Human CellExp™ SARS-CoV-2 Spike Protein (S1; His-tag), Recombinant

P1532-10 10 µg
EUR 156

Human CellExp™ SARS-CoV-2 Spike Protein (S1; His-tag), Recombinant

P1532-50 50 µg
EUR 551

Human CellExp™ SARS-CoV-2 Spike Protein (RBD 310-568), Recombinant

P1543-10 10 µg
EUR 156

Human CellExp™ SARS-CoV-2 Spike Protein (RBD 310-568), Recombinant

P1543-50 50 µg
EUR 480

Human CellExp™ SARS-CoV-2 Spike Protein (RBD; 331-524), Recombinant

P1544-10 10 µg
EUR 156

Human CellExp™ SARS-CoV-2 Spike Protein (RBD; 331-524), Recombinant

P1544-50 50 µg
EUR 480

Recombinant SARS Spike Mosaic S Protein (aa 12-53, 90-115, 171-203)

VAng-Lsx0055-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 12-53, 90-115, 171-203 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant SARS Spike Mosaic S Protein (aa 1051-1076, 1121-1154, 1162-1190)

VAng-Lsx0057-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 1051-1076, 1121-1154, 1162-1190 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant Coronavirus Spike Protein (SARS-CoV S1; 12-53, 90-115, 171-203)

P1515-10 10µg
EUR 156

Recombinant Coronavirus Spike Protein (SARS-CoV S1; 12-53, 90-115, 171-203)

P1515-50 50µg
EUR 551

Recombinant Coronavirus Spike Protein (SARS-CoV S2; 408-470, 540-573, His Tag)

P1517-10 10µg
EUR 257

Sars/ Rat Sars ELISA Kit

ELI-41050r 96 Tests
EUR 886

SARS antibody

70R-20086 50 ul
EUR 435
Description: Rabbit polyclonal SARS antibody
The optimized HIC-MALS technique allows monitoring of the product purity, and concurrently entry its molecular mass, offering orthogonal data complementary to established SEC-MALS strategies. Enhanced resolving energy might be achieved over SEC, attributed to the prolonged variables to tune selectivity in HIC mode.

Leave a Reply

Your email address will not be published. Required fields are marked *